Context Therapeutics Inc.

SEC 4 · Filed

0001628280-26-010642Accepted

Applies to the EDGAR acceptance time.

Other time zone
Insider transactionsEvent date Feb 19, 2026

Grant, award or other acquisition by Minai-Azary Jennifer Lynn

Security
Stock Option (right to buy)
Code
A
Shares
275,000
Price per share
0.00
Structured facts
{
  "code": "A",
  "date": "2026-02-19",
  "direction": "A",
  "exercise_price": "2.32",
  "expiration": "2036-02-18",
  "footnotes": {
    "F1": "The option vests and becomes exercisable over a four-year period. Twenty-five percent (25%) of the option vests and becomes exercisable on February 19, 2027, and the balance vests in equal monthly installments over the remaining three years of the four-year period, subject to continued service with the Issuer."
  },
  "owners": [
    {
      "cik": "0001844398",
      "name": "Minai-Azary Jennifer Lynn",
      "roles": [
        "officer"
      ],
      "title": "Chief Financial Officer"
    }
  ],
  "ownership": "D",
  "post_shares": "275000",
  "price": "0",
  "row": 1,
  "rule_10b5_1": "0",
  "security": "Stock Option (right to buy)",
  "shares": "275000",
  "table": "II",
  "underlying_security": "Common Stock",
  "underlying_shares": "275000"
}